Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
16 May 2024 Job Information Organisation/Company Institut Pasteur Department Microbiology Research Field Medical sciences » Other Researcher Profile First Stage Researcher (R1) Recognised Researcher
-
https://research.pasteur.fr/en/team/biology-of-spirochetes/ Dive into the Fascinating World of Spirochetes ! Do you want to contribute to a project aiming at understanding what makes Leptospira
-
Departments across the Biology/Physics/Biomedical fields. In particular, the fellow will benefit from an exceptional computational infrastructure at the Institut Pasteur BioHub (75 bioinformatics engineers) and
-
, cell biology, biophysics and animal models of infection. This project will take advantage of the vivid scientific environment of the campus and the numerous available core facilities available including
-
patients hospitalized in France at a national level using data from French health databases (SNDS). Applicants should have a Master or Engineering degree or PhD in Biostatistics or Bioinformatics
-
, auditory cognition, genetics and genomics, cell biology and gene therapy. Most teams associate fundamental researchers and MDs and conduct research protocols applicable to humans with clinicians as co
-
5 Apr 2024 Job Information Organisation/Company Institut Pasteur Department Immunology Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1) Country France
-
, computational biology, and molecular evolution. The researcher will work within a multidisciplinary international team (both computational and experimental biologists), that focuses on understanding the future
-
macrophages, and the mechanisms by which viruses perturb mucociliary clearance; the candidate will then harness the organ-on-chip technology to develop a more advanced model of the airway that integrates both
-
A postdoc position for a talented postdoctoral researcher is available in the Bioorganic Chemistry of Nucleic Acids unit of the Pasteur Institute, Paris, France. Topic. mRNA vaccines have advanced